Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2014-04-30
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard treatment + music therapy
Selective serotonin re-uptake inhibitor plus cognitive behavioral therapy. Music therapy encompassing 12 half-hour sessions of therapist-supervised receptive music therapy scheduled over four weeks
Selective serotonin re-uptake inhibitor
A medication of selective serotonin re-uptake inhibitor (SSRI) family, Behavioral. The type and dosage of the medication was decided by the treating psychiatrist.
Cognitive Behavioral Therapy
Cognitive Behavioral Therapy for obsessive compulsive disorder carried out by a psychologist.
Music therapy
12 sessions of 30-minute individual-based receptive music therapy, supervised by the treating psychiatrist.
Standard treatment only
Selective serotonin re-uptake inhibitor plus cognitive behavioral therapy.
Selective serotonin re-uptake inhibitor
A medication of selective serotonin re-uptake inhibitor (SSRI) family, Behavioral. The type and dosage of the medication was decided by the treating psychiatrist.
Cognitive Behavioral Therapy
Cognitive Behavioral Therapy for obsessive compulsive disorder carried out by a psychologist.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Selective serotonin re-uptake inhibitor
A medication of selective serotonin re-uptake inhibitor (SSRI) family, Behavioral. The type and dosage of the medication was decided by the treating psychiatrist.
Cognitive Behavioral Therapy
Cognitive Behavioral Therapy for obsessive compulsive disorder carried out by a psychologist.
Music therapy
12 sessions of 30-minute individual-based receptive music therapy, supervised by the treating psychiatrist.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* had axis I diagnosis of OCD according to the criteria delineated by the diagnostic and statistical manual of mental disorders - fourth edition diagnosed by an experienced psychiatrist
* had not received treatment previously for the disorder
* agreed to partake in the study
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Islamic Azad University, Marvdasht
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shahrzad Shirani
Shahrzad Shirani Bidabadi, M.S.c
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shariati Hospital
Isfahan, Isfahan, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2172719
Identifier Type: -
Identifier Source: org_study_id